Dr. Scott C. Boyd, MD
Urogynecology (Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician)
11123 Parkview Plaza Dr Ste 102
Fort Wayne, IN 46845
Who else practices at this address →
Allen County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 165
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician primary
IN license 01050870A
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Parkview Regional Medical Center Fort Wayne, IN
Medical groups
- Parkview Health System Inc (1,377 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 165
- Services billed
- 1,597
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 82 | 54 |
| Established patient office or other outpatient visit, 30-39 minutes | 78 | 49 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 43 | 43 |
| Electronic assessment of bladder emptying | 43 | 43 |
| Insertion of device into abdomen with pressure and urine flow rate study | 43 | 43 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 40 | 40 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | 31 |
| Urinalysis, manual test | 26 | 20 |
| Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | 21 | 21 |
| New patient office or other outpatient visit, 30-44 minutes | 21 | 21 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Myrbetriq (mirabegron) Other prescribers in Fort Wayne, IN | 189 |
| Gemtesa (vibegron) Other prescribers in Fort Wayne, IN | 179 |
| Solifenacin Succinate Other prescribers in Fort Wayne, IN | 76 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Fort Wayne, IN | 69 |
| Ciprofloxacin Hcl Other prescribers in Fort Wayne, IN | 67 |
| Estradiol Other prescribers in Fort Wayne, IN | 66 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Fort Wayne, IN | 44 |
| Cephalexin Other prescribers in Fort Wayne, IN | 39 |
| Fluconazole Other prescribers in Fort Wayne, IN | 37 |
| Trospium Chloride Other prescribers in Fort Wayne, IN | 36 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 9 payments worth $322 in total to this clinician.
| Boston Scientific Corporation | $108 |
|---|---|
| Sumitomo Pharma America, Inc. | $69.02 |
| Medtronic, Inc. | $64.21 |
| Intuitive Surgical, Inc. | $55.46 |
| Biogen, Inc. | $25.56 |
| Food and Beverage | $322 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $9,126 in research payments for these studies, mostly to the institutions running them.
- Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
Sebela Women's Health Inc. · Active, not recruiting · NCT03633799
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.